selective rev. DNA methyltransferase inhibitor

preclinical eff. at 30 mpk SC BID (xenograft)

from 1.8M cmpd enzymatic HTS + opt.

Nature Cancer

GlaxoSmithKline

Chemical structure of molecule GSK3685032

The GSK DNMT1 inhibitor GSK3685032 is a first-in-class, non-nucleoside, reversible and selective inhibitor of the epigenetic target DNA-methyltransferase 1 (DNMT1). Commonly prescribed hypomethylating agents (HMAs) such as decitabine are incorporated into…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: